Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


EAGLE PHARMACT   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2018201720162015201420132012
Period End Date12/31/201812/31/201712/31/201612/31/20159/30/20149/30/20139/30/2012
Product sales70.3945.3340.6512.974.635.321.16
Royalty income142.93153.8899.048.2610.718.361.38
Other income--37.5049.8045.003.77----
Total Revenue213.31236.71189.4866.2319.1013.682.54
Cost of product sales42.3733.7135.797.76------
Cost of Revenue------7.895.047.383.17
Cost of royalty19.5423.4719.52--6.67----
Research and development44.4232.6128.2927.8616.829.8012.81
Selling, general and administrative60.5171.4253.3320.179.334.966.40
Restructuring charge7.91------------
Legal settlement--(1.65)----------
Asset impairment charges(2.70)(7.24)----------
Gain on sale of asset----1.75--------
Changes in fair value of contingent consideration0.767.38(0.96)--------
Total Operating Expenses176.70162.72136.1363.6737.8622.1322.37
Income (Loss) from operations36.6273.9953.352.56(18.76)(8.46)(19.83)
Interest expense2.741.140.010.010.010.310.09
Net proceeds from arbitration----------(4.05)--
Interest income0.160.090.080.030.030.000.03
Other income/(expense), net--------0.040.000.01
Deferred financing costs----------(0.10)(0.02)
Amortization of debt discount----------(1.09)(0.22)
Change in value of warrant liability--------(0.57)(1.05)--
Loss on subscription loan settlement------------(0.05)
Total other income/(expense), net(2.58)(1.05)0.080.01(0.52)1.51(0.33)
Income (loss) before income tax34.0472.9553.432.57(19.27)(6.95)(20.16)
Income tax (benefit) expenses2.1421.00(28.03)0.00(1.30)(0.90)(0.78)
Net Income (loss)--------(17.98)(6.05)(19.38)
Dividends on Series A, B, B-1 and C Convertible Preferred Stock--------1.673.843.93
Net income (loss) attributable to common stockholders31.9051.9481.452.57(19.64)(9.89)(23.32)
Income (Loss) per share attributable to common stockholders Basic2.163.445.240.17(1.97)(3.25)(14.11)
Income (Loss) per share attributable to common stockholders Diluted2.093.274.960.16(1.97)(3.25)(14.11)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING BASIC14.7715.1015.5315.259.963.041.65
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING DILUTED15.2815.9116.4316.259.963.041.65